Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
UCSF is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.
UCSF researchers now have reported a new method to design and test cell therapies, one they expect will speed the development of new life-saving treatments not only for cancer, but for other diseases, too.
The Science Policy Group at UCSF has initiated a project to provide alcohol-based hand sanitizer to incarcerated populations, as well as people living in public or transitional housing or experiencing homelessness, with plans to distribute 15,000 bottles.
While the widely used coronavirus PCR tests take about four hours to produce a result from a respiratory sample, the new DETECTR test developed by UCSF scientists takes only 45 minutes, rapidly accelerating the pace of diagnosis.
The COVID-19 pandemic is a critical time to think about how best to manage the care of older adults, both for their sake and for the near- and longer-term costs and stresses to the health care system, according to a new commentary by a UCSF clinician.
To meet the pressing need for personal protective equipment for frontline health care workers, a multidisciplinary team has mobilized UCSF’s 3D-printing infrastructure to engineer and produce thousands of face shields.
Pregnant women are at higher risk for many infections, but the risks of COVID-19 to mother and baby are not yet clear. UCSF experts share what we know and don’t know about COVID-19’s effects on pregnancy, the possibility of in utero transmission, and advice for pregnant women.